Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment strategies for clear cell renal cell carcinoma: Past, present and future

21 Mar 2023

Abstract excerpt

Clear cell renal cell carcinoma (ccRCC) is the most prevalent histological subtype of kidney cancer, which is prone to metastasis, recurrence, and resistance to radiotherapy and chemotherapy. The burden it places on human health due to its refractory nature and rising incidence rate is substantial. Researchers have recently determined the ccRCC risk factors and optimized the clinical therapy based on the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37025584
DOI: 10.3389/fonc.2023.1133832

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment strategies for clear cell renal cell carcinoma: Past, present and futurePMID 37025584Read ↗

Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategiesSemantic proximity Read ↗

Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the LiteratureSemantic proximity Read ↗

Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies.Semantic proximity Read ↗

Current updates and future perspectives on the management of renal cell carcinoma.Semantic proximity Read ↗

Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.Semantic proximity Read ↗

Molecular Mechanisms of Drug Resistance in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Incidence and survival patterns of clear cell renal cell carcinoma from 2000 to 2017, based on A SEER DatabaseSemantic proximity Read ↗

Renal cell carcinoma: new insights and challenges for a clinician scientist.Semantic proximity Read ↗

Diagnostic and Prognostic Biomarkers in Renal Clear Cell CarcinomaSemantic proximity Read ↗

Diagnostic and Prognostic Biomarkers in Renal Clear Cell CarcinomaSemantic proximity Read ↗

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Semantic proximity Read ↗

Oncological outcomes of primary renal malignancies other than clear cell renal carcinoma: A retrospective study from a tertiary centerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.